TP53 and diabetes mellitus: One major finding is that the prevention by p53 inhibition of DM-induced cardiac remodeling and dysfunction are associated with both attenuation of the early-stage apoptosis and prevention of the persistent cell senescence and glycolytic and angiogenetic dysfunction.